Fuji Pharma Co., Ltd. (FRA:FUP)

Market Cap	246.25M
Revenue (ttm)	297.62M
Net Income (ttm)	17.28M
Shares Out	n/a
EPS (ttm)	0.71
PE Ratio	14.25
Forward PE	n/a
Dividend	0.27 (2.66%)
Ex-Dividend Date	Sep 29, 2025

Volume	n/a
Average Volume	n/a
Open	10.10
Previous Close	10.30
Day's Range	10.10 - 10.10
52-Week Range	7.25 - 10.30
Beta	n/a
RSI	63.95
Earnings Date	Feb 5, 2026

About Fuji Pharma

Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women, in vitro diagnostics, acute medical care products, and curative medicines, as well as information regarding pharmaceuticals and health; and contract manufacturing services. Fuji Pharma Co., Ltd. was founded in 1959 and is headquartered in Tokyo, Japan.

• Industry: Pharmaceutical Preparations
• Founded: 1959
• Employees: 1,658
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: FUP

Financial Performance

In 2025, Fuji Pharma's revenue was 51.68 billion, an increase of 12.01% compared to the previous year's 46.14 billion. Earnings were 3.00 billion, a decrease of -51.19%.

Financial numbers in JPY